FDA proposed fast-track for critical patients could benefit Pluristem
Linkedin

FDA proposed fast-track for critical patients could benefit Pluristem

Dax : France | Oct 18, 2012 at 7:19 AM PDT
Source: Globes Online
XX XX
Views: Pending
 
US Food and Drug Administration (FDA) Commissioner Margaret Hamburg has told scientific advisers that it considering a faster track for obesity treatments, life-saving antibiotics and other drugs deemed to offer societal benefit. Pluristem is developing placenta-based cell (PLacental eXpanded... FULL ARTICLE AT Globes Online
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

More From Allvoices



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.